chronic-kidney-disease

Documents about chronic-kidney-disease

• GLUcose Transport and REnalPROtection in Chronic Kidney Disease#67851ClinicalTrials.gov
• Different Effects of Non-calcium Phosphate Binders on Serum Calcium#329396ClinicalTrials.gov
• An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice#329412ClinicalTrials.gov
• Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population#343790ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease#349885ClinicalTrials.gov
• A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD#350031ClinicalTrials.gov
• Evaluation of Fructose Ingestion and the Renin Angiotensin System in Humans#363498ClinicalTrials.gov
• Association of pruritus with comorbidities and survival in chronic kidney disease: a narrative review of the pre-difelikefalin era literature#4623Europe PMC
• Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease#8233HAL (France)
• The Omics‐Driven Machine Learning Path to Cost‐Effective Precision Medicine in Chronic Kidney Disease#11603HAL (France)
• Translational research on cognitive impairment in chronic kidney disease#14437HAL (France)
• In silico prediction of optimal multifactorial intervention in chronic kidney disease#26083HAL (France)
• Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review#68179HAL (France)
• Association of pruritus with comorbidities and survival in chronic kidney disease: a narrative review of the pre-difelikefalin era literature#68400HAL (France)
• Blocking Sphingosine 1‐phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney Disease#280333HAL (France)
• Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus#280369HAL (France)
• Association of Tryptophan Metabolites with Cognitive Impairment in Chronic Kidney Disease#294643HAL (France)

Related topics